Cargando…

The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial

An application (app) for the Severe Respiratory Insufficiency Questionnaire (SRI) has been designed and developed for mobile devices. In a randomised controlled trial comprising 60 patients with chronic respiratory failure, the app was compared with the classic paper SRI. Thereby, it was shown that...

Descripción completa

Detalles Bibliográficos
Autores principales: Majorski, Daniel Sebastian, Schwarz, Sarah Bettina, Magnet, Friederike Sophie, Ahmad, Rebar, Mathes, Tim, Windisch, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311098/
https://www.ncbi.nlm.nih.gov/pubmed/33653932
http://dx.doi.org/10.1136/thoraxjnl-2020-216319
_version_ 1783728894449287168
author Majorski, Daniel Sebastian
Schwarz, Sarah Bettina
Magnet, Friederike Sophie
Ahmad, Rebar
Mathes, Tim
Windisch, Wolfram
author_facet Majorski, Daniel Sebastian
Schwarz, Sarah Bettina
Magnet, Friederike Sophie
Ahmad, Rebar
Mathes, Tim
Windisch, Wolfram
author_sort Majorski, Daniel Sebastian
collection PubMed
description An application (app) for the Severe Respiratory Insufficiency Questionnaire (SRI) has been designed and developed for mobile devices. In a randomised controlled trial comprising 60 patients with chronic respiratory failure, the app was compared with the classic paper SRI. Thereby, it was shown that the SRI app is a practical tool that is well accepted. Missing values can be completely avoided by using the SRI app. Finally, reliability, convergent and discriminant validities were established. Accordingly, for the individual SRI subscales, Cronbach’s alpha ranged between 0.56 and 0.81 (app) and between 0.54 and 0.83 (paper), respectively. The multilingual SRI app is accessible free of charge for non-profit research purposes.
format Online
Article
Text
id pubmed-8311098
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-83110982021-08-13 The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial Majorski, Daniel Sebastian Schwarz, Sarah Bettina Magnet, Friederike Sophie Ahmad, Rebar Mathes, Tim Windisch, Wolfram Thorax Brief Communication An application (app) for the Severe Respiratory Insufficiency Questionnaire (SRI) has been designed and developed for mobile devices. In a randomised controlled trial comprising 60 patients with chronic respiratory failure, the app was compared with the classic paper SRI. Thereby, it was shown that the SRI app is a practical tool that is well accepted. Missing values can be completely avoided by using the SRI app. Finally, reliability, convergent and discriminant validities were established. Accordingly, for the individual SRI subscales, Cronbach’s alpha ranged between 0.56 and 0.81 (app) and between 0.54 and 0.83 (paper), respectively. The multilingual SRI app is accessible free of charge for non-profit research purposes. BMJ Publishing Group 2021-08 2021-03-02 /pmc/articles/PMC8311098/ /pubmed/33653932 http://dx.doi.org/10.1136/thoraxjnl-2020-216319 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Brief Communication
Majorski, Daniel Sebastian
Schwarz, Sarah Bettina
Magnet, Friederike Sophie
Ahmad, Rebar
Mathes, Tim
Windisch, Wolfram
The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
title The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
title_full The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
title_fullStr The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
title_full_unstemmed The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
title_short The Severe Respiratory Insufficiency Application (SRI App): a pilot randomised controlled trial
title_sort severe respiratory insufficiency application (sri app): a pilot randomised controlled trial
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311098/
https://www.ncbi.nlm.nih.gov/pubmed/33653932
http://dx.doi.org/10.1136/thoraxjnl-2020-216319
work_keys_str_mv AT majorskidanielsebastian thesevererespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT schwarzsarahbettina thesevererespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT magnetfriederikesophie thesevererespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT ahmadrebar thesevererespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT mathestim thesevererespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT windischwolfram thesevererespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT majorskidanielsebastian severerespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT schwarzsarahbettina severerespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT magnetfriederikesophie severerespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT ahmadrebar severerespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT mathestim severerespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial
AT windischwolfram severerespiratoryinsufficiencyapplicationsriappapilotrandomisedcontrolledtrial